Liang Yuqing, Liu Tengwen, Wang Dong, Liu Qingquan
School of Basic Medical Sciences, Chengdu University of Traditional Chinese Medicine, Chengdu, China.
Beijing Hospital of Traditional Chinese Medicine, Capital Medical University, Beijing, China.
Front Pharmacol. 2025 Mar 19;16:1538311. doi: 10.3389/fphar.2025.1538311. eCollection 2025.
Infectious diseases continue to be a major global public health concern, which is exacerbated by the increasing prevalence of antimicrobial resistance. This review investigates the potential of herbal medicine, particularly (CM) and (CI), in addressing these challenges. Both herbs, documented in traditional Chinese medicine (TCM) and the Pharmacopoeia of the People's Republic of China (2020 edition), are renowned for their heat-clearing and detoxifying properties. Phytochemical studies reveal that these botanicals contain diverse bioactive compounds, including flavonoids, terpenoids, and phenylpropanoids, which exhibit antimicrobial, anti-inflammatory, and antioxidant properties, among other effects. Comparative analysis reveals that distinct compound profiles and differential concentrations of core phytochemicals between CM and CI may lead to differentiated therapeutic advantages in anti-infective applications. By systematically examining their ethnopharmacological origins, phytochemical fingerprints, and pharmacological mechanisms, this review highlights their synergistic potential with conventional antimicrobial therapies through multi-target mechanisms, proposing novel integrative approaches for global health challenges.
传染病仍然是全球主要的公共卫生问题,而抗菌药物耐药性的日益普遍使这一问题更加严重。本综述探讨了草药医学,特别是中药(CM)和中药(CI)在应对这些挑战方面的潜力。这两种草药在中国传统医学(TCM)和《中华人民共和国药典》(2020年版)中均有记载,以其清热排毒特性而闻名。植物化学研究表明,这些植物含有多种生物活性化合物,包括黄酮类、萜类和苯丙素类,它们具有抗菌、抗炎和抗氧化等作用。比较分析表明,CM和CI之间不同的化合物谱和核心植物化学物质的不同浓度可能导致在抗感染应用中具有不同的治疗优势。通过系统地研究它们的民族药理学起源、植物化学指纹图谱和药理机制,本综述强调了它们通过多靶点机制与传统抗菌疗法协同的潜力,为全球卫生挑战提出了新的综合方法。